This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2016-2017.
Company Filing History:
2 out of 834,350 Years Active: 2016-2017
Title: Preethy Paul: Innovator in Pharmaceutical Compositions
Introduction
Preethy Paul is a notable inventor based in Turku, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at cancer treatment. With a total of 2 patents, his work focuses on innovative solutions for combating viral-related cancers.
Latest Patents
Preethy Paul’s latest patents include groundbreaking pharmaceutical compositions of Anisomelic acid. These compositions are designed for anti-viral cancer treatment in mammals. They comprise a therapeutically effective amount of Anisomelic acid or its salts. The formulations may be presented in an oil-in-water emulsion, which includes an isotropic mixture of at least one oil and one surfactant. Alternatively, they can be formulated in a hydrophilic solvent along with co-solvents or surfactants. Additionally, a method for treating or preventing cancer in mammals, particularly where the p53 pathway is deregulated by viral oncoproteins, is also provided.
Career Highlights
Throughout his career, Preethy Paul has worked with various companies, contributing his expertise to the pharmaceutical industry. His innovative approach has led to advancements in cancer treatment methodologies.
Collaborations
Preethy has collaborated with notable individuals in his field, including John E Eriksson and Emilia Peuhu. Their combined efforts have furthered research and development in pharmaceutical compositions.
Conclusion
Preethy Paul stands out as an influential inventor in the realm of pharmaceutical innovations. His work on Anisomelic acid compositions showcases his commitment to advancing cancer treatment options.